A new study may have found a target for a potential drug for Parkinson's disease
The tau and alpha-synuclein proteins
In Parkinson's, alpha-synuclein behaves much like tau in Alzheimer's. We reasoned that if AEP cuts tau, it's very likely that it will cut alpha-synuclein too."
AEP and neurotoxicity in Parkinson's